Created with sketchtool.

Resources to utilize in your practice and with your patients

Downloadable Information


Links


A20A225B-C94A-4FAA-8269-16B492B3EA87 Created with sketchtool.
Resources for your patients
Share valuable resources, such as the Mentor Program, with your patients to provide them support throughout treatment.
Supportive Care Voucher Program
  • Up to 3 months’ free supply per antidiarrheal product
  • Availabled to all patients
  • Used at the dispensing pharmacy, with prescription(s) at local retail pharmacy, or through Puma Specialty Pharmacy network
Speaker Program Registration
Join us to learn more about protecting patients with NERLYNX. Gain valuable information, such as:
  • Current unmet need in HER2+ breast cancer and NERLYNX MOA

  • Clinical outcomes for reducing the risk of recurrence and assessing patient risk factors

  • Safety, dosing, and tolerability strategies

IMPORTANT SAFETY INFORMATION

NERLYNX® (neratinib) tablets, for oral use

INDICATIONS AND USAGE: NERLYNX is a kinase inhibitor indicated:

CONTRAINDICATIONS: None

WARNINGS AND PRECAUTIONS:

ADVERSE REACTIONS: The most common adverse reactions (reported in ≥5% of patients) were:

To report SUSPECTED ADVERSE REACTIONS, contact Puma Biotechnology, Inc. at 1-844-NERLYNX (1-844-637-5969) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

DRUG INTERACTIONS:

USE IN SPECIFIC POPULATIONS:

For Full Prescribing Information, please click here.